Megan G Hofmeister
Overview
Explore the profile of Megan G Hofmeister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofmeister M, Ly K, Yin S, Spradling P
J Viral Hepat
. 2024 Sep;
31(12):783-794.
PMID: 39225298
Hepatitis A is a vaccine-preventable disease that typically causes mild illness. Hepatitis A outbreaks associated with person-to-person transmission have been widespread in the United States since 2016. We used public-use...
2.
Hofmeister M, Zhong Y, Moorman A, Teshale E, Samuel C, Spradling P
Public Health Rep
. 2024 Jul;
140(1):115-124.
PMID: 39057103
Objectives: In the United States, hepatitis C is the most commonly reported bloodborne infection. It is a leading cause of liver cancer and death from liver disease and imposes a...
3.
Scobie H, Negus S, Stevenson T, Bressler S, Bruden D, Simons B, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae417.
PMID: 39050226
We evaluated factors associated with the presence of hepatitis A virus antibodies 23 years after initiating vaccination at ages 6-15 months. Among 67 participants, 86% (42/49) of those vaccinated at...
4.
Hall E, Bradley H, Barker L, Lewis K, Shealey J, Valverde E, et al.
Hepatology
. 2024 May;
81(2):625-636.
PMID: 38739849
Background And Aims: The National Health and Nutrition Examination Survey (NHANES) underestimates the true prevalence of HCV infection. By accounting for populations inadequately represented in NHANES, we created 2 models...
5.
Hofmeister M, Gupta N
MMWR Morb Mortal Wkly Rep
. 2023 Oct;
72(42):1128-1133.
PMID: 37856325
Hepatitis A is acquired through the fecal-oral route and is preventable by a safe and effective vaccine. Although hepatitis A is generally mild and self-limited, serious complications, including death, can...
6.
Hofmeister M, Yin S, Nelson N, Weng M, Gupta N
Public Health Rep
. 2023 Jul;
333549231184007.
PMID: 37480244
Objectives: The incidence of hepatitis A declined in the United States following the introduction of hepatitis A vaccines, before increasing in the setting of recent widespread outbreaks associated with person-to-person...
7.
Hofmeister M, Zhong Y, Moorman A, Samuel C, Teshale E, Spradling P
Clin Infect Dis
. 2023 Jul;
77(12):1668-1675.
PMID: 37463305
Background: Hospitalization burden related to hepatitis C virus (HCV) infection is substantial. We sought to describe temporal trends in hospitalization rates before and after release of direct-acting antiviral (DAA) agents....
8.
Jones J, Agarwal A, Moorman A, Hofmeister M, Hulse J, Meneveau M, et al.
Transplant Direct
. 2023 Jul;
9(8):e1506.
PMID: 37456591
Methods: In 2018, 2 kidneys and a liver were procured from a deceased donor resident of Kentucky, one of many states that was experiencing an HAV outbreak associated with person-to-person...
9.
Conners E, Panagiotakopoulos L, Hofmeister M, Spradling P, Hagan L, Harris A, et al.
MMWR Recomm Rep
. 2023 Mar;
72(1):1-25.
PMID: 36893044
Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and...
10.
Foster M, Hofmeister M, Yin S, Montgomery M, Weng M, Eckert M, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Sep;
71(39):1229-1234.
PMID: 36173747
Hepatitis A is a vaccine-preventable disease typically acquired through fecal-oral transmission. Hepatitis A virus (HAV) infection rates in the United States declined approximately 97% during 1995-2015 after the introduction and...